Edwards Lifesciences (EW)

Cost of Revenue

$1.44B

TTM · Period ending: · USD

EW logo

EW Cost of Revenue

Latest reported$1.44B
EW TTM Cost of Revenue ($436.20M → $1.44B)
High-resolution chart · PNG

EW cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
420,600,000
426,400,000
436,200,000
416,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.